Brainsway Ltd (BWAY NASDAQ) stock market data APIs
$10.5154
0.05(0.5%)
as of June 6, 2025
Try our APIs with
free plan!
Brainsway Ltd Financial Data Overview
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Prev. Close
10.5154
Open
10.5665
High
10.5049
Low
10.1932
52 wk Range
5.67-11.79
Market Cap
203 M
P/E Ratio
47.5
Shares Outstanding
18 883 K
Revenue
43 457 K
EPS
0.02
Beta
0.254
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Brainsway Ltd data using free add-ons & libraries
Get Brainsway Ltd Fundamental Data
Brainsway Ltd Fundamental data includes:
- Net Revenue: 43 457 K
- EBITDA: 3 239 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-06
- EPS/Forecast: 0.0233
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Brainsway Ltd News
New
7 High-Growth Stocks to Snag for Spectacular Returns in 2024
In the stock market, pursuing high-growth stocks becomes a compelling venture, akin to searching for pearls in the vast sea of possibilities. The year 2024 unfolds with promises of prosperity and stra...
Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January
From CRISPR gene editing to modify ideal agricultural traits, synthetic biology to promote eco-friendly engineering, or even that relating to biofuels, the field of biotechnology, also known as biotec...
7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough
A cadre of quietly thriving companies has been making significant strategic strides in a market where giants often grab the spotlight. These under-the-radar stocks are positioning themselves for a rem...
Market Mavericks: 3 Stocks That Could Turn $10K into $100K by 2027
Pinpointing stocks with the potential for exponential growth requires extreme efforts on the market terrain. However, delving into the strategic prowess and distinctive approaches of the three standou...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
